中外女性健康研究
中外女性健康研究
중외녀성건강연구
Women's Health Research
2015年
9期
1-2
,共2页
慢性阻塞性肺疾病(COPD)%脑钠肽(BNP)%左心功能衰竭%II型呼吸衰竭
慢性阻塞性肺疾病(COPD)%腦鈉肽(BNP)%左心功能衰竭%II型呼吸衰竭
만성조새성폐질병(COPD)%뇌납태(BNP)%좌심공능쇠갈%II형호흡쇠갈
Chronic obstructive pulmonary disease (COPD)%Brain natriuretic peptide (BNP)%Left ventricular failure%Type II respiratory failure
目的：通过对慢性阻塞性肺病（COPD）患者的血清脑钠肽(BNP)进行检测，了解血清脑钠肽水平在慢性阻塞性肺疾病患者身上的应用价值。方法：收集并整理93例不同病情情况下慢性阻塞性肺疾病患者入院时血清脑钠肽结果，并加以分组，结合临床进行分析。结果：单纯COPD急性加重期患者的血清脑钠肽水平较COPD急性加重伴左心功能衰竭、II型呼吸衰竭伴高血压患者具有显著差异，P＜0.01。COPD急性加重伴左心功能衰竭与II型呼吸衰竭伴高血压之间差异无统计学意义，P＞0.05。结论：COPD急性加重期患者，如同时伴有左心功能衰竭、II型呼吸衰竭或高血压等，血清脑钠肽水平较单纯COPD急性加重患者明显增高，BNP作为心脏标志物，可以为COPD患者的诊断、治疗及判断预后提供科学的依据。
目的：通過對慢性阻塞性肺病（COPD）患者的血清腦鈉肽(BNP)進行檢測，瞭解血清腦鈉肽水平在慢性阻塞性肺疾病患者身上的應用價值。方法：收集併整理93例不同病情情況下慢性阻塞性肺疾病患者入院時血清腦鈉肽結果，併加以分組，結閤臨床進行分析。結果：單純COPD急性加重期患者的血清腦鈉肽水平較COPD急性加重伴左心功能衰竭、II型呼吸衰竭伴高血壓患者具有顯著差異，P＜0.01。COPD急性加重伴左心功能衰竭與II型呼吸衰竭伴高血壓之間差異無統計學意義，P＞0.05。結論：COPD急性加重期患者，如同時伴有左心功能衰竭、II型呼吸衰竭或高血壓等，血清腦鈉肽水平較單純COPD急性加重患者明顯增高，BNP作為心髒標誌物，可以為COPD患者的診斷、治療及判斷預後提供科學的依據。
목적：통과대만성조새성폐병（COPD）환자적혈청뇌납태(BNP)진행검측，료해혈청뇌납태수평재만성조새성폐질병환자신상적응용개치。방법：수집병정리93례불동병정정황하만성조새성폐질병환자입원시혈청뇌납태결과，병가이분조，결합림상진행분석。결과：단순COPD급성가중기환자적혈청뇌납태수평교COPD급성가중반좌심공능쇠갈、II형호흡쇠갈반고혈압환자구유현저차이，P＜0.01。COPD급성가중반좌심공능쇠갈여II형호흡쇠갈반고혈압지간차이무통계학의의，P＞0.05。결론：COPD급성가중기환자，여동시반유좌심공능쇠갈、II형호흡쇠갈혹고혈압등，혈청뇌납태수평교단순COPD급성가중환자명현증고，BNP작위심장표지물，가이위COPD환자적진단、치료급판단예후제공과학적의거。
Objective: To explore the application value of serum brain natriuretic peptide (BNP) testing for chronic obstructive pulmonary disease (COPD) patients at various conditions by study the relation between the BNP level and the severity of the disease. Methods: 93 cases of COPD patients with different severity were collected and the test data of their serum brain natriuretic peptide were grouped and analyzed. Results: The serum BNP values of the acute exacerbation of COPD patients are significantly different from that of the patients with acute exacerbation of COPD combined with left ventricular failure, or type II respiratory failure and hypertension (P <0.01). Serum BNP values of exacerbation COPD patients with left ventricular failure have no significant difference with that of the COPD patients with type II respiratory failure and hypertension (P>0.05). Conclusion: Acute exacerbation COPD patients, if combined with left ventricular failure, type II respiratory failure, or high blood pressure, the serum BNP levels are much higher than that of the acute exacerbation COPD patients. So the BNP, as the cardiac marker, can be used in diagnose, treatment, and prognosis of COPD patients.
